Pivotal Trials For EU Approval Still Underrepresent Minorities, Study Finds
Roma, Europe’s Largest Minority, Not Represented At All
Data on minority groups were frequently underreported, and in many cases numbers have not improved with time, according to the study by Tufts CSDD.
You may also be interested in...
Could The US FDA Set Clinical Trial Diversity Minimums?
Oncology Center of Excellence Director Richard Pazdur asked whether the FDA should have more conversations with sponsors about site selection and percentages of US participants.
How To Improve Diversity And Inclusion: Five Companies Share Best Practices
Company strategies at improving diversity, equity and inclusion both within their organizations and in the clinical trials they conduct have differed, but building trust is a common theme.
Sanofi Tries To ‘Bring More Of The Outside In’ For Diversity Efforts
The company is focusing first on gender parity as it navigates around tricky legal frameworks on collecting demographic data.